Efficacy and tolerability of newer antihistamines in the treatment of allergic conjunctivitis (Q28301040)

https://scigraph.springernature.com/pub.10.2165/00003495-200565020-00004

Europe PubMed Central

title

Efficacy and tolerability of newer antihistamines in the treatment of allergic conjunctivitis (English)

0 references

1 reference

allergic conjunctivitis

1 reference

1

Leonard Bielory

0 references

author name string

Kenneth W Lien

series ordinal

2

0 references

Steve Bigelsen

series ordinal

3

0 references

language of work or name

English

0 references

publication date

2005

0 references

published in

Drugs

0 references

volume

65

0 references

issue

2

0 references

page(s)

215-28

0 references

exact match

0 references

cites work

Terfenadine and fexofenadine reduce in vitro ICAM-1 expression on human continuous cell lines.

1 reference

12 December 2020

The effects of acute doses of fexofenadine, promethazine, and placebo on cognitive and psychomotor function in healthy Japanese volunteers

1 reference

12 December 2020

Azelastine eye-drops in seasonal allergic conjunctivitis or rhinoconjunctivitis. A double-blind, randomized, placebo-controlled study

1 reference

12 December 2020

Topical cyclosporin A in the management of vernal keratoconjunctivitis

1 reference

12 December 2020

Detection by brush cytology of mast cells and eosinophils in allergic and vernal conjunctivitis

1 reference

12 December 2020

Studies on the novel antiallergic agent HSR-609: its penetration into the central nervous system in mice and guinea pigs and its selectivity for the histamine H1-receptor

1 reference

12 December 2020

Inhibition of human eosinophil chemotaxis in vitro by the anti-allergic agent emedastine difumarate

1 reference

12 December 2020

Efficacy and tolerability of ophthalmic epinastine: a randomized, double-masked, parallel-group, active- and vehicle-controlled environmental trial in patients with seasonal allergic conjunctivitis

1 reference

12 December 2020

Clinical evaluation of twice-daily emedastine 0.05% eye drops (Emadine eye drops) versus levocabastine 0.05% eye drops in patients with allergic conjunctivitis

1 reference

12 December 2020

Binding characteristics of [3H]levocetirizine to cloned human H1-histamine-receptors expressed in CHO cells

1 reference

12 December 2020

Antihistaminic and antiallergic properties of dextro-mequitamium iodide in upper and lower guinea pig airways: comparison with azelastine

1 reference

12 December 2020

Comparison of ketotifen fumarate ophthalmic solution alone, desloratadine alone, and their combination for inhibition of the signs and symptoms of seasonal allergic rhinoconjunctivitis in the conjunctival allergen challenge model: a double-masked, p

1 reference

12 December 2020

Comparative study of clinical efficacy and tolerance in seasonal allergic conjunctivitis management with 0.1% olopatadine hydrochloride versus 0.05% ketotifen fumarate

1 reference

12 December 2020

Comparison of the topical ocular antiallergic efficacy of emedastine 0.05% ophthalmic solution to ketorolac 0.5% ophthalmic solution in a clinical model of allergic conjunctivitis.

1 reference

12 December 2020

The efficacy and safety of fexofenadine HCl and pseudoephedrine, alone and in combination, in seasonal allergic rhinitis

1 reference

12 December 2020

Olopatadine inhibits anti-immunoglobulin E-stimulated conjunctival mast cell upregulation of ICAM-1 expression on conjunctival epithelial cells

1 reference

12 December 2020

Effectiveness and safety of fexofenadine, a new nonsedating H1-receptor antagonist, in the treatment of fall allergies

1 reference

12 December 2020

Characterization of the ocular antiallergic and antihistaminic effects of olopatadine (AL-4943A), a novel drug for treating ocular allergic diseases

1 reference

12 December 2020

Cetirizine reduces conjunctival nonspecific hyperreactivity in children with mite allergy

1 reference

12 December 2020

Topical azelastine in perennial allergic conjunctivitis

1 reference

12 December 2020

Double-blind comparison of levocabastine eye drops with sodium cromoglycate and placebo in the treatment of seasonal allergic conjunctivitis

1 reference

12 December 2020

Comparative study of 0.1% olopatadine hydrochloride and 0.5% ketorolac tromethamine in the treatment of seasonal allergic conjunctivitis

1 reference

12 December 2020

Azelastine is more potent than olopatadine n inhibiting interleukin-6 and tryptase release from human umbilical cord blood-derived cultured mast cells

1 reference

12 December 2020

Double-masked, randomized, placebo-controlled clinical study of the mast cell-stabilizing effects of treatment with olopatadine in the conjunctival allergen challenge model in humans

1 reference

12 December 2020

Emedastine: a potent, high affinity histamine H1-receptor-selective antagonist for ocular use: receptor binding and second messenger studies.

1 reference

12 December 2020

The effects of single-dose fexofenadine, diphenhydramine, and placebo on cognitive performance in flight personnel

1 reference

12 December 2020

Antimuscarinic effects of antihistamines: quantitative evaluation by receptor-binding assay

1 reference

12 December 2020

A randomized trial of topical cyclosporin 0.05% in topical steroid-resistant atopic keratoconjunctivitis

1 reference

12 December 2020

Comparative pharmacology of H1 antihistamines: clinical relevance

1 reference

12 December 2020

Pharmacokinetics, pharmacodynamics, and tolerance of single- and multiple-dose fexofenadine hydrochloride in healthy male volunteers

1 reference

12 December 2020

Effect of levocabastine, a new H1 antagonist, in a conjunctival provocation test with allergens

1 reference

12 December 2020

An evaluation of onset and duration of action of patanol (olopatadine hydrochloride ophthalmic solution 0.1%) compared to Claritin (loratadine 10 mg) tablets in acute allergic conjunctivitis in the conjunctival allergen challenge model

1 reference

12 December 2020

Conjunctivitis medicamentosa

1 reference

12 December 2020

An efficacy and tolerance comparison of emedastine difumarate 0.05% and levocabastine hydrochloride 0.05%: reducing chemosis and eyelid swelling in subjects with seasonal allergic conjunctivitis. Emadine Study Group

1 reference

12 December 2020

Effects of fexofenadine, diphenhydramine, and placebo on performance of the test of variables of attention (TOVA).

1 reference

12 December 2020

Cetirizine. A reappraisal of its pharmacological properties and therapeutic use in selected allergic disorders

1 reference

12 December 2020

Comparison of emedastine 0.05% or nedocromil sodium 2% eye drops and placebo in controlling local reactions in subjects with allergic conjunctivitis

1 reference

12 December 2020

Protective effect of loratadine on specific conjunctival provocation test.

1 reference

12 December 2020

Ocular tolerability and safety of ketotifen fumarate ophthalmic solution

1 reference

12 December 2020

In vitro and in vivo studies of the non-sedating antihistamine epinastine

1 reference

12 December 2020

A double-blind evaluation of topical levocabastine, a new specific H1 antagonist in patients with allergic conjunctivitis

1 reference

12 December 2020

Comparison of the efficacy, safety and quality of life provided by fexofenadine hydrochloride 120 mg, loratadine 10 mg and placebo administered once daily for the treatment of seasonal allergic rhinitis.

1 reference

12 December 2020

Single dose of ketotifen fumarate .025% vs 2 weeks of cromolyn sodium 4% for allergic conjunctivitis.

1 reference

12 December 2020

Ocular drying associated with oral antihistamines (loratadine) in the normal population-an evaluation of exaggerated dose effect.

1 reference

12 December 2020

Studies on the ocular pharmacology of prostaglandin D2.

1 reference

12 December 2020

H2-receptors in the human ocular surface

1 reference

12 December 2020

Ketotifen fumarate and olopatadine hydrochloride in the treatment of allergic conjunctivitis: a real-world comparison of efficacy and ocular comfort

1 reference

12 December 2020

Efficacy and safety of fexofenadine hydrochloride for treatment of seasonal allergic rhinitis

1 reference

12 December 2020

Effects of nedocromil sodium on airway neurogenic mechanisms

1 reference

12 December 2020

Efficacy and safety of cyclosporine eyedrops in vernal keratoconjunctivitis.

1 reference

12 December 2020

Vernal keratoconjunctivitis in Thailand.

1 reference

12 December 2020

Topical ocular levocabastine reduces ICAM-1 expression on epithelial cells both in vivo and in vitro

1 reference

12 December 2020

A randomized, placebo-controlled trial of topical cyclosporin A in steroid-dependent atopic keratoconjunctivitis

1 reference

12 December 2020

Efficacy of an oral antihistamine, loratadine, as compared with a nasal steroid spray, beclomethasone dipropionate, in seasonal allergic rhinitis

1 reference

12 December 2020

Efficacy of ketotifen fumarate 0.025% ophthalmic solution compared with placebo in the conjunctival allergen challenge model

1 reference

12 December 2020

Blocking ICAM-1 (CD54) and LFA-1 (CD11a) inhibits experimental allergic conjunctivitis

1 reference

12 December 2020

Effect of emedastine difumarate on CC chemokine-elicited eosinophil migration

1 reference

12 December 2020

Azelastine eye drops reduce and prevent allergic conjunctival reaction and exert anti-allergic activity

1 reference

12 December 2020

Evaluation of 0.05% levocabastine versus 4% sodium cromolyn in the allergen challenge model

1 reference

12 December 2020

Comparison of the combinations of fexofenadine-pseudoephedrine and loratadine-montelukast in the treatment of seasonal allergic rhinitis

1 reference

12 December 2020

Allergic subjects express intercellular adhesion molecule--1 (ICAM-1 or CD54) on epithelial cells of conjunctiva after allergen challenge

1 reference

12 December 2020

Evaluation of olopatadine, a new ophthalmic antiallergic agent with dual activity, using the conjunctival allergen challenge model

1 reference

12 December 2020

Safety and efficacy of once-daily fexofenadine HCl in the treatment of autumn seasonal allergic rhinitis.

1 reference

12 December 2020

Azelastine inhibits secretion of IL-6, TNF-alpha and IL-8 as well as NF-kappaB activation and intracellular calcium ion levels in normal human mast cells

1 reference

12 December 2020

Comparison of the efficacy of combined fluticasone propionate and olopatadine versus combined fluticasone propionate and fexofenadine for the treatment of allergic rhinoconjunctivitis induced by conjunctival allergen challenge

1 reference

12 December 2020

Olopatadine inhibits TNFalpha release from human conjunctival mast cells

1 reference

12 December 2020

Topical levocabastine is more effective than sodium cromoglycate for the prophylaxis and treatment of seasonal allergic conjunctivitis

1 reference

12 December 2020

Topical levocabastine compared with oral loratadine for the treatment of seasonal allergic rhinoconjunctivitis. Swedish GP Allergy Team

1 reference

12 December 2020

A randomized, double-blind, placebo-controlled comparison of emedastine 0.05% ophthalmic solution with loratadine 10 mg and their combination in the human conjunctival allergen challenge model

1 reference

12 December 2020

Effect of cetirizine in a conjunctival provocation test with allergens

1 reference

12 December 2020

Selective displacement of [3H]mepyramine from peripheral vs. central nervous system receptors by loratadine, a non-sedating antihistamine

1 reference

12 December 2020

Comparison of azelastine eye drops with levocabastine eye drops in the treatment of seasonal allergic conjunctivitis

1 reference

12 December 2020

Effects of fexofenadine and other antihistamines on components of the allergic response: adhesion molecules

1 reference

12 December 2020

Protective effect of loratadine on late phase reaction induced by conjunctival provocation test

1 reference

12 December 2020

Pharmacokinetics of cetirizine in tear fluid after a single oral dose

1 reference

12 December 2020

Randomized, double-masked comparison of olopatadine ophthalmic solution, mometasone furoate monohydrate nasal spray, and fexofenadine hydrochloride tablets using the conjunctival and nasal allergen challenge models

1 reference

12 December 2020

An evaluation of the effects of high-dose fexofenadine on the central nervous system: a double-blind, placebo-controlled study in healthy volunteers

1 reference

12 December 2020

Fexofenadine is efficacious and safe in children (aged 6-11 years) with seasonal allergic rhinitis

1 reference

12 December 2020

Supplementation of fexofenadine therapy with nedocromil sodium 2% ophthalmic solution to treat ocular symptoms of seasonal allergic conjunctivitis

1 reference

12 December 2020

Efficacy and tolerability of ophthalmic epinastine assessed using the conjunctival antigen challenge model in patients with a history of allergic conjunctivitis

1 reference

12 December 2020

Comparison of the efficacy and tolerability of topically administered azelastine, sodium cromoglycate and placebo in the treatment of seasonal allergic conjunctivitis and rhino-conjunctivitis

1 reference

12 December 2020

Inhibitory effects of ketotifen on eotaxin‐dependent activation of eosinophils: consequences for allergic eye diseases

1 reference

12 December 2020

Efficacy and safety of desloratadine in the treatment of perennial allergic rhinitis

1 reference

12 December 2020

Comparison of topical 0.05% levocabastine and 0.1% lodoxamide in patients with allergic conjunctivitis. Study Group

1 reference

12 December 2020

A single-center, randomized, double-blind, placebo-controlled, crossover investigation of the effects of fexofenadine hydrochloride 180 mg alone and with alcohol, with hydroxyzine hydrochloride 50 mg as a positive internal control, on aspects of cog

1 reference

12 December 2020

Cetirizine reduces inflammatory cell recruitment and ICAM-1 (or CD54) expression on conjunctival epithelium in both early- and late-phase reactions after allergen-specific challenge

1 reference

12 December 2020

Ocular allergy: implications for the clinical immunologist

1 reference

12 December 2020

Double-blind, placebo-controlled study comparing the efficacy and safety of fexofenadine hydrochloride (120 and 180 mg once daily) and cetirizine in seasonal allergic rhinitis

1 reference

12 December 2020

Effect of ketotifen on the production of reactive oxygen species from human eosinophils primed by eotaxin.

1 reference

12 December 2020

Allergic and immunologic disorders of the eye. Part I: immunology of the eye.

1 reference

12 December 2020

The added benefit of local Patanol therapy when combined with systemic Claritin for the inhibition of ocular itching in the conjunctival antigen challenge model

1 reference

12 December 2020

Nedocromil sodium and levocabastine reduce the symptoms of conjunctival allergen challenge by different mechanisms

1 reference

12 December 2020

Comparison of the clinical efficacy and comfort of olopatadine hydrochloride 0.1% ophthalmic solution and nedocromil sodium 2% ophthalmic solution in the human conjunctival allergen challenge model

1 reference

12 December 2020

Emedastine ophthalmic solution 0.05% versus levocabastine ophthalmic suspension 0.05% in the treatment of allergic conjunctivitis using the conjunctival allergen challenge model

1 reference

12 December 2020